XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue $ 45,311 $ 33,729
Cost of revenue, exclusive of amortization shown below 16,069 15,560
Amortization expense 4,525 6,168
Total cost of revenue 20,594 21,728
Gross profit 24,717 12,001
Operating expenses:    
Sales and marketing 37,150 25,175
Research and development 10,727 9,782
General and administrative 18,209 15,824
Transaction costs 3,099 0
Depreciation and amortization 5,408 5,211
Total operating expenses 74,593 55,992
Loss from continuing operations (49,876) (43,991)
Change in fair value of embedded derivative liability (78,497) 0
Interest expense, net (3,190) (4,088)
Other expenses, net (515) (1,640)
Loss from continuing operations before income taxes (132,078) (49,719)
Income tax expense of continuing operations (2,434) (1,842)
Net loss from continuing operations (134,512) (51,561)
Net income from discontinued operations, net of tax 60,037 1,136
Net loss $ (74,475) $ (50,425)
Income (loss) per share:    
Net loss from continuing operations per share of common stock - basic (in dollars per share) $ (3.37) $ (3.75)
Net loss from continuing operations per share of common stock - diluted (in dollars per share) (1.10) (3.75)
Net income from discontinued operations per share of common stock - basic (in dollars per share) 1.50 0.08
Net income from discontinued operations per share of common stock - diluted (in dollars per share) $ 1.18 $ 0.08
Weighted-average shares used in computation:    
Basic (in shares) 39,951,865 13,757,550
Diluted (in shares) 50,934,670 13,757,550